Interestingly, we observed a tendency of increase in macrophage numbers in mice with NASH treated with IL-1β blocker, while Ccl2 gene expression was slightly diminished by the treatment. Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.